Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|15|1|57-70

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.15, Iss.1, 2016-12, pp. : 57-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The NMDA Receptor as a Therapeutic Target in Major Depressive Disorder

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 2, 2007-01 ,pp. : 101-115

Bentham Science Publishers

Access to resources Recommend Favorite

Vilazodone: In Major Depressive Disorder

By Frampton James E.  

CNS Drugs, Vol. 25, Iss. 7, 2011-07 ,pp. : 615-627

Adis International

Access to resources Recommend Favorite

Aripiprazole: In Major Depressive Disorder

By Weber Juliane   Lyseng-Williamson Katherine A.   Scott Lesley J.  

CNS Drugs, Vol. 22, Iss. 10, 2008-01 ,pp. : 807-813

Adis International

Access to resources Recommend Favorite

Agomelatine for the treatment of major depressive disorder

By Carney Regina M   Shelton Richard C  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 15, 2011-10 ,pp. : 2411-2419

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for major depressive disorder

By Kennedy Sidney H   Rizvi Sakina J  

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 3, 2009-09 ,pp. : 439-453

Informa Healthcare

Access to resources Recommend Favorite